Skip to main content
. 2018 Mar 12;148(3):437–444. doi: 10.1093/jn/nxx061

TABLE 4.

Association between the DII and healthy aging, secondary analyses1

T1DII T2DII T3DII P-trend2 DII (continuous) P-continuous
≥6 dietary records3
 Model 14 1 (–) 1.09 (0.96, 1.23) 0.87 (0.76, 1.00) 0.04 0.97 (0.94, 1.00) 0.06
 Model 25 1 (–) 1.08 (0.95, 1.22) 0.86 (0.74, 1.01) 0.06 0.97 (0.94, 1.00) 0.07
 Model 36 1 (–) 1.08 (0.96, 1.22) 0.87 (0.74, 1.01) 0.07 0.97 (0.94, 1.00) 0.08
Placebo group7
 Model 14 1 (–) 0.99 (0.83, 1.18 0.81 (0.66, 0.98) 0.03 0.97 (0.93, 1.02) 0.21
 Model 25 1 (–) 0.97 (0.81, 1.16) 0.80 (0.64, 0.99) 0.04 0.97 (0.92, 1.02) 0.27
 Model 36 1 (–) 0.97 (0.81, 1.16) 0.80 (0.64, 1.00) 0.04 0.97 (0.92, 1.02) 0.26
Active group8
 Model 14 1 (–) 1.07 (0.92, 1.26) 0.94 (0.79, 1.12) 0.46 0.99 (0.96, 1.03) 0.66
 Model 25 1 (–) 1.06 (0.90, 1.24) 0.91 (0.75, 1.10) 0.33 0.98 (0.94, 1.02) 0.43
 Model 36 1 (–) 1.07 (0.91, 1.26) 0.92 (0.76, 1.11) 0.39 0.99 (0.95, 1.03) 0.50
1

Values are RRs (95% CIs), estimated through robust-error-term Poisson regression models. DII, Dietary Inflammatory Index; T, tertile.

2

P for trend.

3

At least six 24-h records: n = 2445. T1: n = 815; T2: n = 815; T3: n = 815.

4

Model 1 is adjusted for sex, supplementation group (except in analyses stratified according to supplementation group), age, follow-up duration.

5

Model 2 is adjusted as for Model 1 + number of 24-h records, daily energy intake, education level, occupational status, living arrangement, smoking status, and physical activity.

6

Model 3 is adjusted as for Model 2 + BMI.

7

Placebo group: n = 1313. T1: n = 437; T2: n = 438; T3: n = 438.

8

Active group: n = 1483. T1: n = 494; T2: n = 495; T3: n = 494.